Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Assessment of anti-PD-(L)1 for patients with coexisting malignant tumor and tuberculosis classified by active, latent, and obsolete stage

Fig. 4

Representative cases and treatment response. A Patient #2 who was diagnosed with lung squamous cell cancer (SqCC) and pulmonary tuberculosis (PTB) received anti-tuberculosis treatment for 5 months followed by immunotherapy. B Patient #16 with cutaneous squamous cell carcinoma (CSCC) and PTB started anti-tuberculosis treatment for 1 month followed by immunotherapy

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us